BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol 2021; 27(35): 5803-5821 [PMID: 34629804 DOI: 10.3748/wjg.v27.i35.5803]
URL: https://www.wjgnet.com/1007-9327/full/v27/i35/5803.htm
Number Citing Articles
1
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
2
Markos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, Stephanos Vassilopoulos, Ingrid Lazaridou, Eleftherios Mylonakis, Kittichai Promrat, Jack R. Wands. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2023; 21(7): 1708 doi: 10.1016/j.cgh.2023.01.001
3
Chun-Yi Wang, Hsiang-Han Kao, Kuan-Yu Lai, Ching-Chun Lin, Wen-Yuan Lin, Chiu-Shong Liu, Tsung-Po Chen. Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional StudyMetabolites 2022; 12(10): 893 doi: 10.3390/metabo12100893
4
Akira Sasaki, Akira Umemura, Kazuyuki Ishida, Naoto Takahashi, Haruka Nikai, Hiroyuki Nitta, Yasuhiro Takikawa, Keisuke Kakisaka, Tamami Abe, Masao Nishiya, Tamotsu Sugai. The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical FeaturesBiomedicines 2022; 10(2): 453 doi: 10.3390/biomedicines10020453
5
Pei Chia Eng, Roberta Forlano, Tricia Tan, Pinelopi Manousou, Waljit S. Dhillo, Chioma Izzi-Engbeaya. Non-alcoholic fatty liver disease in women – Current knowledge and emerging conceptsJHEP Reports 2023; 5(10): 100835 doi: 10.1016/j.jhepr.2023.100835
6
Michelle J Allen, Rachael Doran, David Brain, Elizabeth E Powell, James O’Beirne, Patricia C Valery, Adrian Barnett, Ruvini Hettiarachchi, Ingrid J Hickman, Sanjeewa Kularatna. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levelsBMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09934-2
7
Neues zur Fettleber: Nomenklatur, Screening-Empfehlungen, Therapiebemühungen und andere klinisch relevante AspekteZeitschrift für Gastroenterologie 2023; 61(10): 1419 doi: 10.1055/a-2149-7976
8
Tanmoy Mondal, Coleman I. Smith, Christopher A. Loffredo, Ruth Quartey, Gemeyel Moses, Charles D. Howell, Brent Korba, Bernard Kwabi-Addo, Gail Nunlee-Bland, Leanna R. Rucker, Jheannelle Johnson, Somiranjan Ghosh. Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †International Journal of Molecular Sciences 2023; 24(23): 16654 doi: 10.3390/ijms242316654
9
Michael H. Storandt, Sri Harsha Tella, Mikolaj A. Wieczorek, David Hodge, Julia K. Elrod, Philip S. Rosenberg, Zhaohui Jin, Amit Mahipal. Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United StatesCancers 2024; 16(4): 684 doi: 10.3390/cancers16040684
10
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. Hígado graso (parte 2): enfoque clínico y tratamientoRevista colombiana de Gastroenterología 2023; 38(1): 46 doi: 10.22516/25007440.979
11
Adnan Khan, Heather M. Ross, Natalia Salinas Parra, Sarah L. Chen, Kashyap Chauhan, Makala Wang, Brian Yan, John Magagna, Jake Beiriger, Yash Shah, Taha Shahzad, Dina Halegoua-DeMarzio. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)Livers 2022; 2(4): 264 doi: 10.3390/livers2040022
12
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Soghra Rabizadeh, Mojdeh Sarzaeim, Amirhossein Yadegar, Fatemeh Mohammadi, Razman Arabzadeh Bahri, Peyman Pakravan, Paria Shafiekhani, Manouchehr Nakhjavani, Alireza Esteghamati. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysisLipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01802-6
13
Barbara Janota, Elżbieta Szczepańska, Brygida Adamek, Ewa Janczewska. Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?World Journal of Hepatology 2023; 15(5): 641-648 doi: 10.4254/wjh.v15.i5.641
14
Mohamed El-Kassas, Abeer Awad, Mohamed Elbadry, Juan Pablo Arab. Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseSeminars in Liver Disease 2024; 44(01): 054 doi: 10.1055/a-2253-9181
15
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828